Skip to main content

Evaluation of Switching Patterns in FDA’s Sentinel System – A New Tool to Assess the Substitutability of Generic Drugs

Basic Details
Date
Type
Presentation
Materials

Evaluation of Switching Patterns in FDA’s Sentinel System – A New Tool to Assess the Substitutability of Generic Drugs

Information
Host

34th International Conference on Pharmacoepidemiology & Therapeutic Risk Management

Related Assessment(s)
Abstracts of the 34th International Conference on Pharmacoepidemiology & Therapeutic Risk Management, Prague Congress Centre, Prague, Czech Republic, August 22–26, 2018 | Abstract 802
Identify and Evaluate Manufacturer-Level Drug Utilization and Switching Patterns in Sentinel
Evaluation of Switching Patterns in FDA's Sentinel System: A New Tool to Assess Generic Drugs
Presenter(s)

Sarah K. Dutcher, Jennifer R. Popovic, Michael Nguyen, Sukhminder K. Sandhu, Patty Greene, Rima Izem, Wenlei Jiang, Zhong Wang, Yueqin Zhao, Andrew B. Petrone, Anita K. Wagner, Joshua J. Gagne